INDUSTRY NEWS

THE NEXT STEP
Rayner has launched a new ophthalmic viscosurgical device (OVD) – Ophteis® FR Pro. 
“A revolution in OVDs, Ophteis® FR Pro with sorbitol is unparalleled in protecting the corneal endothelium from free radical energy caused by phacoemulsification,” said a company spokeswoman.
“Since Sir Harold Ridley’s first intraocular lens implant in 1949, there have been several innovative leaps forward, such as the invention of foldable lenses, development of phaco techniques, and use of OVDs to alleviate the risk of anterior chamber collapse and tissue damage by surgical instruments. However, as technology evolves, so must the surgical environment,” she added. 
“Rayner’s Ophteis® FR Pro is a uniquely bio-engineered OVD containing sorbitol, added at four per cent concentration to the two per cent NaHA. Sorbitol is a highly stable antioxidant molecule, found naturally in the aqueous humour. When combined in Ophteis® FR Pro, sorbitol has a neutralising or ‘scavenging’ effect on free radicals, enabling a new level of corneal endothelial protection from phaco induced trauma.”

www.rayner.com

CE MARK APPROVAL

Smart Vision Labs, a maker of portable and smart autorefractors, has announced that SVOne has received CE mark approval, which grants the company entitlement to market and sell the device in European countries. 
The company says that SVOne, a handheld Shack-Hartmann wavefront aberrometer, accurately measures objective refractive error in children and adults. 
“The CE mark is a significant step forward in the commercialisation of SVOne in Europe,” said COO and co-founder Marc Albanese. 
“We’ve had a lot of interest from this market. With the CE Mark, our company’s mission to make vision care globally accessible will be even more attainable,” he added.
www.smartvisionlabs.com